This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Astrazeneca Ab. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Glen Andrews: Innovator in Pharmaceutical Compounds
Introduction
Glen Andrews is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on phenoxypyridinylamide compounds. His research focuses on developing compounds that can be utilized in the treatment of various diseases.
Latest Patents
Glen Andrews holds a patent for phenoxypyridinylamide compounds. The present invention provides a compound of a specific formula, wherein the variables are defined in the patent documentation. This invention also details a process for preparing such a compound and its application in treating a PDE4 mediated disease state. He has 1 patent to his name.
Career Highlights
Glen Andrews is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to the development of innovative treatments that address critical health issues.
Collaborations
Glen has collaborated with several talented individuals in his field, including Rhona Jane Cox and Christopher De Savi. These collaborations have enhanced the research and development efforts within his projects.
Conclusion
Glen Andrews is a dedicated inventor whose work in phenoxypyridinylamide compounds showcases his commitment to advancing pharmaceutical science. His contributions are vital in the ongoing quest for effective treatments for complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile